Evidence map›Paper›PMID 31356623›Full record

ArticlePLoS pathogens2019

Cryptococcus neoformans resists to drastic conditions by switching to viable but non-culturable cell phenotype.

Benjamin Hommel, Aude Sturny-Leclère, Stevenn Volant, Nathanaël Veluppillai, Magalie Duchateau, Chen-Hsin Yu, Véronique Hourdel, Hugo Varet, Mariette Matondo, John R Perfect and 3 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. bioRxiv : the preprint server for biology · 2025
    Article
  10. Review
  11. Review
  12. Peroxisomes regulate virulence and cell density sensing inbioRxiv : the preprint server for biology · 2025
    Article
  13. Article
  14. Observational
  15. Article
  16. Unveiling new features of the human pathogenComputational and structural biotechnology journal · 2025
    Article
  17. Discovery of CONature microbiology · 2024
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Benjamin HommelInstitut Pasteur, CNRS, Molecular Mycology Unit, UMR2000, Paris, France.ORCID 0000-0003-0971-1696
Aude Sturny-LeclèreInstitut Pasteur, CNRS, Molecular Mycology Unit, UMR2000, Paris, France.
Stevenn VolantInstitut Pasteur - Bioinformatics and Biostatistics Hub - C3BI, USR 3756 IP CNRS, Paris, France.
Nathanaël VeluppillaiInstitut Pasteur, CNRS, Molecular Mycology Unit, UMR2000, Paris, France.ORCID 0000-0001-7834-8398
Magalie DuchateauInstitut Pasteur, Unité de spectrométrie de masse et Protéomique, Paris, France.ORCID 0000-0001-5475-3065
Chen-Hsin YuDivision of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
Véronique HourdelInstitut Pasteur, Unité de spectrométrie de masse et Protéomique, Paris, France.
Hugo VaretInstitut Pasteur - Bioinformatics and Biostatistics Hub - C3BI, USR 3756 IP CNRS, Paris, France.
Mariette MatondoInstitut Pasteur, Unité de spectrométrie de masse et Protéomique, Paris, France.
John R PerfectDivision of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.
Arturo CasadevallDepartment of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.ORCID 0000-0002-9402-9167
Françoise DromerInstitut Pasteur, CNRS, Molecular Mycology Unit, UMR2000, Paris, France.ORCID 0000-0003-1671-1475
Alexandre AlanioInstitut Pasteur, CNRS, Molecular Mycology Unit, UMR2000, Paris, France.ORCID 0000-0001-9726-3082
Centre National de la Recherche Scientifique · FRInstitut Pasteur · FRDuke Medical Center · USJohns Hopkins University · US

Funding

Synergy of Host Defense Mechanisms in the LungR01HL059842 · NHLBI · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 1997 to 2023
$7.4M
Biology of Fungal MelaninR01AI052733 · NIAID · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 2003 to 2019
$6.6M
PROTECTIVE ANTIBODIES FOR CRYPTOCOCCAL INFECTIONSR01AI033774 · NIAID · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 1994 to 2014
$5.6M
Pathobiology of C. neoformans in the Central Nervous SystemR01AI073896 · NIAID · DUKE UNIVERSITY · PI PERFECT, JOHN R. · 2008 to 2018
$4.4M
Molecular Characterization of C. neoformans AntibodiesR37AI033142 · NIAID · JOHNS HOPKINS UNIVERSITY · PI CASADEVALL, ARTURO · 2007 to 2016
$3.9M
Evolution of Cryptococcus neoformans Strains from Patients with HIV/AIDSR01AI093257 · NIAID · DUKE UNIVERSITY · PI PERFECT, JOHN R. · 2011 to 2022
$3.8M
NHLBI NIH HHS R01 HL059842NIAID NIH HHS R01 AI033774NIAID NIH HHS R01 AI052733NIAID NIH HHS R01 AI073896NIAID NIH HHS R01 AI093257NIAID NIH HHS R37 AI033142
6 · The paper itself

Abstract

Metabolically quiescent pathogens can persist in a viable non-replicating state for months or even years. For certain infectious diseases, such as tuberculosis, cryptococcosis, histoplasmosis, latent infection is a corollary of this dormant state, which has the risk for reactivation and clinical disease. During murine cryptococcosis and macrophage uptake, stress and host immunity induce Cryptococcus neoformans heterogeneity with the generation of a sub-population of yeasts that manifests a phenotype compatible with dormancy (low stress response, latency of growth). In this subpopulation, mitochondrial transcriptional activity is regulated and this phenotype has been considered as a hallmark of quiescence in stem cells. Based on these findings, we worked to reproduce this phenotype in vitro and then standardize the experimental conditions to consistently generate this dormancy in C. neoformans. We found that incubation of stationary phase yeasts (STAT) in nutriment limited conditions and hypoxia for 8 days (8D-HYPOx) was able to produced cells that mimic the phenotype obtained in vivo. In these conditions, mortality and/or apoptosis occurred in less than 5% of the yeasts compared to 30-40% of apoptotic or dead yeasts upon incubation in normoxia (8D-NORMOx). Yeasts in 8D-HYPOx harbored a lower stress response, delayed growth and less that 1% of culturability on agar plates, suggesting that these yeasts are viable but non culturable cells (VBNC). These VBNC were able to reactivate in the presence of pantothenic acid, a vitamin that is known to be involved in quorum sensing and a precursor of acetyl-CoA. Global metabolism of 8D-HYPOx cells showed some specific requirements and was globally shut down compared to 8D-NORMOx and STAT conditions. Mitochondrial analyses showed that the mitochondrial mass increased with mitochondria mostly depolarized in 8D-HYPOx compared to 8D-NORMox, with increased expression of mitochondrial genes. Proteomic and transcriptomic analyses of 8D-HYPOx revealed that the number of secreted proteins and transcripts detected also decreased compared to 8D-NORMOx and STAT, and the proteome, secretome and transcriptome harbored specific profiles that are engaged as soon as four days of incubation. Importantly, acetyl-CoA and the fatty acid pathway involving mitochondria are required for the generation and viability maintenance of VBNC. Altogether, these data show that we were able to generate for the first time VBNC phenotype in C. neoformans. This VBNC state is associated with a specific metabolism that should be further studied to understand dormancy/quiescence in this yeast.

Indexed as

AnimalsCryptococcosisCryptococcus neoformansCulture MediaFatty AcidsFungal ProteinsHumansMiceMicrobial ViabilityMitochondriaOxygenPantothenic AcidPhenotypeTranscriptomeCulture MediaFatty AcidsFungal ProteinsOxygenPantothenic Acid

Identifiers

PMID31356623
PMCPMC6687208
OpenAlexW2964356093

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.